GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Meta] the Zepbound rule is doing its job and people should stop complaining — 32 comments in the full submission. View in context.
2.3k
c/tirzepatide·submitted 2 months ago by u/kian_ekstrom

[Meta] the Zepbound rule is doing its job and people should stop complaining

Titrationbranch of 7 comments

Posting this because I searched for it and got nothing useful. Setup: 10mg, week 76, injection-site soreness present but not ruining anything. I changed exactly one variable — SURPASS — and tracked it for 7 weeks. Result: a difference, but a small one, and well inside what I would call noise if someone else posted…

Read the full submission and all 32 comments →

This branch

7 comments, started 2 months ago
u/dexa_twice_yearlyMOD137 points·2 months ago

Removed a chain here. The rule is one line long and it is not negotiable.

replysharereportpermalink
u/ahmed_fonseca113 points·2 months ago·edited

stalled on sema, tried tirz, and the curves were actually different shapes

replysharereportpermalink
u/tarek_kirchner80 points·2 months ago

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

replysharereportpermalink
u/noor_hovland37 points·2 months ago

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/amara_halonen34 points·2 months ago

week 21 on Mounjaro and the appetite profile is genuinely different from sema

replysharereportpermalink
u/nordic_pricing28 points·2 months ago·edited

the GIP side does different things than the GLP-1 side, that is the point

replysharereportpermalink
u/blunt_coldbox2932 points·2 months ago

Slight fix: the number was 97.6, not 98.0. Decimal point, but a fairly consequential one.

replysharereportpermalink

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/tirzepatide
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/titration_marshalu/incretin_ivyu/quiet_moderatoru/dexa_twice_yearly
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →